Interview with Mahaletchumy Arujanan, Executive Director, Malaysian…
How would you describe MABIC today and the way that it has evolved since its creation in 2000? The Malaysian Biotech Information Centre or MABIC is an NGO and part…
Address: Malaysian Biotechnology Information Centre (MABIC)
2-5-51, Monash University Malaysia
Jalan Lagoon Selatan, Bandar Sunway
46150 Petaling Jaya
Selangor D E
MALAYSIA
Tel: +603-5514 6178
The Malaysian Biotechnology Information Centre (MABIC) was set up in June 2000 to bridge the information gap amongst various stakeholder groups and to make technical information more accessible to non-technical individuals. MABIC is a not-for-profit, local node of a global network, with sister offices across all continents. MABIC’s parent institute is International Service for the Acquisition of Agri-biotech Applications (ISAAA). The aime of the Information Centre is to generate and foster closer relations amongst various stakeholders in order to enhance the exchange of information and knowledge these groups. MABIC strives to provide a platform where important issues in biotechnology can be explored and discussed.
Seminars, workshops and public forum are organised in collaboration with interested parties to create public awareness and to inform stakeholders of the current issues in biotechnology. MABIC also facilitates dialogues between stakeholder groups encouraging broad perspective discussions on various biotech topics. Additionally, MABIC also releases a series of publication on a weekly, monthly and quarterly basis.
With a mission to provide scientifically accurate and fact-based resources to all the stakeholders, MABIC strives to support the Government’s efforts in developing biotechnology as a tool for national development.
How would you describe MABIC today and the way that it has evolved since its creation in 2000? The Malaysian Biotech Information Centre or MABIC is an NGO and part…
The biggest pharma stories from Southeast Asia, including GSK’s new HPF manufacturing investment, license suspensions for Samco Farma and Ciubros Farma after Indonesia’s acute kidney injury crisis, Kalbe’s Aventis share…
Eurasia Group’s Aditya Bhattacharji discusses the relatively modest scope of Malaysia’s recently-launched ‘MYSalam’ scheme; a healthcare programme which aims to provide coverage to the country’s bottom 40 percent of earners.…
After 61 years of single-party rule, the May 2018 electoral victory of the populist Pakatan Harapan (PH) coalition sent shockwaves through the Malaysian political landscape. This has been keenly felt…
Click here to download the Healthcare & Life Sciences Review Malaysia 2018. After recent elections conducted in May 2018 saw Mahathir Mohamad returning as Prime Minister after 15 years to…
American medtech giant Baxter and pan-Asian healthcare service provider Zuellig Pharma have been collaborating in Malaysia to increase the quality and quantity of care that can be given to patients…
Sherene Azli, CEO of the Malaysia Healthcare Travel Council (MHTC), introduces this unique organization in charge of promoting Malaysia internationally as the ‘Cardiology and Fertility Hub of Asia’ and explains…
Rashidah Ibrahim, executive director of Malaysian Vaccines & Pharmaceuticals (MVP), tells the story of MVP as the sole animal vaccines manufacturer in Malaysia. She also explains how important animal health…
Chuwn Leong Ch’ng, CEO of Thunder Print, presents his company’s strategic role within the Malaysian healthcare industry to provide a high-quality packaging services for all type of health products, from…
Robert Kruit, chief executive for Zuellig Malaysia and Brunei, discusses Zuellig’s plans to expand beyond distribution and diversify its offering in the healthcare sector, and how Zuellig’s investments into digital…
Tan Sri Dato’ Ariffin Yusuf, founder and managing director of Primabumi, explains how he came to build Primabumi in 1975 and how he managed to position the company as a…
Halal pharmaceuticals – medicines that do not contain any alcohol, parts of animals such as dogs, pigs, bees, or any other substances prohibited as ‘haram’ under Shariah law – are…
Lee Yee Keng, head of healthcare sector of KPMG in Malaysia, highlights the opportunities Malaysia can offer to the healthcare industry, including its potential for private-public partnerships, and how the…
See our Cookie Privacy Policy Here
